Literature DB >> 28882976

Endobronchial Carcinoid Tumor Totally Occluding the Left Main Bronchus Without Producing Symptoms of Bronchial Obstruction.

Diamantis I Tsilimigras1, Demetrios Moris2, Ioannis Ntanasis-Stathopoulos3, Davide Patrini4, Nikolaos Panagiotopoulos4.   

Abstract

BACKGROUND: Bronchial carcinoid tumors (BCTs) are rare neuroendocrine neoplasms of the lung that mainly have a central distribution. They are classified as typical and atypical, with the former variant generally conferring a more favorable survival. Central tumors are usually symptomatic with features of bronchial obstruction, whereas peripheral tumors may remain silent. CASE REPORT: A 36-year-old woman presented to our hospital due to an episode of massive hemoptysis 5 days prior to admission. She had experienced another episode of hemoptysis 4 years before, for which a chest x-ray had shown no pathological findings. A new chest x-ray showed complete collapse of the left lung, with remarkable tracheal deviation. Computed tomography revealed a large endobronchial lesion causing occlusion of the left main bronchus and significant mediastinal shift to the left. Despite the collapse of the left lung, no symptoms of bronchial obstruction were evident. The patient underwent a successful left pneumonectomy and pathology of the resected specimen revealed a typical stage pT2b N1 Mx endobronchial carcinoid tumor.
CONCLUSION: Central tumors are usually symptomatic with features of bronchial obstruction, whereas peripheral tumors may remain silent. Although a significant amount of bronchial occlusion may be present, symptoms of obstruction might not be apparent. Hemoptysis should always be thoroughly investigated, as it may be the only sign of a severe underlying disease. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Pneumonectomy; mediastinal shift; tracheal deviation

Mesh:

Year:  2017        PMID: 28882976      PMCID: PMC5656846          DOI: 10.21873/invivo.11164

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  11 in total

Review 1.  Management of carcinoid tumors.

Authors:  Frank C Detterbeck
Journal:  Ann Thorac Surg       Date:  2010-03       Impact factor: 4.330

2.  Prognostic model of survival for typical bronchial carcinoid tumours: analysis of 1109 patients on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours Working Group.

Authors:  Pier Luigi Filosso; Francesco Guerrera; Andrea Evangelista; Stefan Welter; Pascal Thomas; Paula Moreno Casado; Erino Angelo Rendina; Federico Venuta; Luca Ampollini; Alessandro Brunelli; Franco Stella; Mario Nosotti; Federico Raveglia; Valentina Larocca; Ottavio Rena; Stefano Margaritora; Francesco Ardissone; William D Travis; Inderpal Sarkaria; Dariusz Sagan
Journal:  Eur J Cardiothorac Surg       Date:  2015-01-05       Impact factor: 4.191

3.  Acromegaly due to production of a growth hormone releasing factor by a bronchial carcinoid tumor.

Authors:  S M Shalet; C G Beardwell; I A MacFarlane; M L Ellison; C M Norman; L H Rees; M Hughes
Journal:  Clin Endocrinol (Oxf)       Date:  1979-01       Impact factor: 3.478

4.  Operative risk and prognostic factors of typical bronchial carcinoid tumors.

Authors:  X Ducrocq; P Thomas; G Massard; P Barsotti; R Giudicelli; P Fuentes; J M Wihlm
Journal:  Ann Thorac Surg       Date:  1998-05       Impact factor: 4.330

5.  Predictors of Disease-free Survival and Recurrence in Patients with Resected Bronchial Carcinoid Tumors.

Authors:  Paul C Lee; Nonso C Osakwe; Navnett Narula; Jeffrey L Port; Subroto Paul; Brendon M Stiles; Weston G Andrews; Abu Nasar; Nasser K Altorki
Journal:  Thorac Cardiovasc Surg       Date:  2015-03-10       Impact factor: 1.827

Review 6.  Pulmonary and thymic carcinoid tumors.

Authors:  M E Dusmet; M F McKneally
Journal:  World J Surg       Date:  1996-02       Impact factor: 3.352

Review 7.  Neuroendocrine neoplasms of the lung. A clinicopathologic update.

Authors:  W H Warren; L P Faber; V E Gould
Journal:  J Thorac Cardiovasc Surg       Date:  1989-09       Impact factor: 5.209

8.  Bronchopulmonary Kulchitzky cell carcinomas. A new classification scheme for typical and atypical carcinoids.

Authors:  R R Paladugu; J R Benfield; H Y Pak; R K Ross; R L Teplitz
Journal:  Cancer       Date:  1985-03-15       Impact factor: 6.860

9.  Bronchial carcinoid tumors: nodal status and long-term survival after resection.

Authors:  Giuseppe Cardillo; Francesco Sera; Marco Di Martino; Paolo Graziano; Roberto Giunti; Luigi Carbone; Francesco Facciolo; Massimo Martelli
Journal:  Ann Thorac Surg       Date:  2004-05       Impact factor: 4.330

10.  Bronchial carcinoid tumors: twenty years' experience.

Authors:  T R Todd; J D Cooper; D Weissberg; N C Delarue; F G Pearson
Journal:  J Thorac Cardiovasc Surg       Date:  1980-04       Impact factor: 5.209

View more
  1 in total

1.  Analysis of diagnostic characteristics and clinical related factors of 70 patients with atelectasis by painless bronchoscopy.

Authors:  Qiang Li; Jun Sun; Xuefen Shuai; Junqing Ren; Xuedong Chen
Journal:  Pak J Med Sci       Date:  2022 Jul-Aug       Impact factor: 2.340

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.